E.D. Salter

538 total citations
12 papers, 430 citations indexed

About

E.D. Salter is a scholar working on Physiology, Immunology and Molecular Biology. According to data from OpenAlex, E.D. Salter has authored 12 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in E.D. Salter's work include Asthma and respiratory diseases (6 papers), Mast cells and histamine (3 papers) and Phosphodiesterase function and regulation (3 papers). E.D. Salter is often cited by papers focused on Asthma and respiratory diseases (6 papers), Mast cells and histamine (3 papers) and Phosphodiesterase function and regulation (3 papers). E.D. Salter collaborates with scholars based in United States. E.D. Salter's co-authors include E. R. Pettipher, Henry J. Showell, John B. Cheng, R Breslow, Anthony J. Milici, R. Griffiths, H Stukenbrok, Ronald P. Gladue, Jeff M. Labasi and Maryrose J. Conklyn and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

E.D. Salter

12 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E.D. Salter United States	10	160	147	140	84	56	12	430
Richard Armer United Kingdom	9	171 1.1×	101 0.7×	161 1.1×	94 1.1×	31 0.6×	27	493
Thomas R. Hundley United States	12	111 0.7×	214 1.5×	142 1.0×	136 1.6×	32 0.6×	14	477
Ermengilda McCauley United States	9	92 0.6×	104 0.7×	117 0.8×	123 1.5×	39 0.7×	11	382
Angela Styhler Canada	14	132 0.8×	78 0.5×	194 1.4×	137 1.6×	31 0.6×	19	482
Silvi Luell United States	15	99 0.6×	116 0.8×	265 1.9×	54 0.6×	55 1.0×	21	590
Mitsuyuki Kuroki United States	10	106 0.7×	145 1.0×	245 1.8×	35 0.4×	74 1.3×	11	461
Valentina Fabbroni Italy	9	80 0.5×	122 0.8×	153 1.1×	133 1.6×	55 1.0×	12	476
Kazuki Murakami Japan	14	70 0.4×	117 0.8×	223 1.6×	60 0.7×	46 0.8×	29	525
Sandra F. Falkenhein United States	9	194 1.2×	119 0.8×	126 0.9×	120 1.4×	17 0.3×	13	452
Chantal Cossette Canada	13	201 1.3×	144 1.0×	149 1.1×	88 1.0×	11 0.2×	23	523

Countries citing papers authored by E.D. Salter

Since Specialization

Citations

This map shows the geographic impact of E.D. Salter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.D. Salter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.D. Salter more than expected).

Fields of papers citing papers by E.D. Salter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.D. Salter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.D. Salter. The network helps show where E.D. Salter may publish in the future.

Co-authorship network of co-authors of E.D. Salter

This figure shows the co-authorship network connecting the top 25 collaborators of E.D. Salter. A scholar is included among the top collaborators of E.D. Salter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.D. Salter. E.D. Salter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Robinson, Ralph P., Leonard Buckbinder, Matthew R. Reese, et al.. (2009). Octahydrophenanthrene-2,7-diol Analogues as Dissociated Glucocorticoid Receptor Agonists: Discovery and Lead Exploration. Journal of Medicinal Chemistry. 52(6). 1731–1743. 36 indexed citations

Chambers, Robert, John B. Cheng, Douglas A. Fisher, et al.. (2005). A new chemical tool for exploring the role of the PDE4D isozyme in leukocyte function. Bioorganic & Medicinal Chemistry Letters. 16(3). 718–721. 4 indexed citations

Showell, Henry J., Maryrose J. Conklyn, Gary P. Hingorani, et al.. (1998). The Preclinical Pharmacological Profile of the Potent and Selective Leukotriene B4 Antagonist CP-195543. Journal of Pharmacology and Experimental Therapeutics. 285(3). 946–954. 37 indexed citations

Kleinman, Edward F., Victoria L. Cohan, John B. Cheng, et al.. (1998). Striking Effect of Hydroxamic Acid Substitution on the Phosphodiesterase Type 4 (PDE4) and TNFα Inhibitory Activity of Two Series of Rolipram Analogues: Implications for a New Active Site Model of PDE4. Journal of Medicinal Chemistry. 41(3). 266–270. 51 indexed citations

Chambers, Robert, Anthony Marfat, John B. Cheng, et al.. (1997). Biarylcarboxamide inhibitors of phosphodiesterase IV and tumor necrosis factor-α. Bioorganic & Medicinal Chemistry Letters. 7(6). 739–744. 8 indexed citations

Faraci, W. Stephen, A. Nagel, Lawrence A. Vincent, et al.. (1996). 2‐Amino‐4‐methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo. British Journal of Pharmacology. 119(6). 1101–1108. 53 indexed citations

Gladue, Ronald P., Anthony J. Milici, H Stukenbrok, et al.. (1996). Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis.. The Journal of Experimental Medicine. 183(4). 1893–1898. 74 indexed citations

Pettipher, E. R. & E.D. Salter. (1996). Resident joint tissues, rather than infiltrating neutrophils and monocytes, are the predominant sources of TNF-α in zymosan-induced arthritis. Cytokine. 8(2). 130–133. 23 indexed citations

Pettipher, E. R., et al.. (1996). Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram. British Journal of Pharmacology. 117(7). 1530–1534. 43 indexed citations

10.

Showell, Henry J., E. R. Pettipher, Juan Cheng, et al.. (1995). The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.. Journal of Pharmacology and Experimental Therapeutics. 273(1). 176–184. 53 indexed citations

11.

Pettipher, E. R., E.D. Salter, & Henry J. Showell. (1994). Effect of in vivo desensitization to leukotriene B₄ on eosinophil infiltration in response to C5a in guinea‐pig skin. British Journal of Pharmacology. 113(1). 117–120. 15 indexed citations

12.

Pettipher, E. R., E.D. Salter, R Breslow, Loretta Raycroft, & Henry J. Showell. (1993). Specific inhibition of leukotriene B₄ (LTB₄)‐induced neutrophil emigration by 20‐hydroxy LTB₄: implications for the regulation of inflammatory responses. British Journal of Pharmacology. 110(1). 423–427. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact